Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure
NCT ID: NCT07019636
Last Updated: 2025-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
314 participants
INTERVENTIONAL
2025-09-15
2027-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ventilation Strategies During Spontaneous Breathing Trial
NCT02939963
ONE-HOUR POSITIVE PRESSURE VENTILATION AFTER A PRESSURE SUPPORT SPONTANEOUS BREATHING TRIAL: A RANDOMIZED CLINICAL TRIAL
NCT07324460
Mechanical Ventilation Reconnection for One Hour After Spontaneous Breathing Trial
NCT05999526
High Flow Oxygen During Spontaneous Breathing Trial in Patients With High Weaning Risk Failure: Impact on the Weaning Course at D7 From the First Spontaneous Breathing Trial.
NCT03689309
Performance of the Variation in Arterial Lactatemia During a Spontaneous Breathing Trial (SBT) in the Prediction of Extubation Failure
NCT05487573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The result of the SBT (passed of failed) is often viewed as a "go - no go" indicator of whether or not patients are ready for extubation, but daily practice indicates that the assessment of the SBT is subjective with a frequent natural tendency for clinicians to keep their patients on the 'safe' side, i.e., considering them as not being ready for extubation. However, the results of the SBT should be interpreted based on the pre-test probability. Conducting a SBT in patients while the pre-test probability of success is high will result in false negatives which are likely to delay the decision of extubation. In addition, a pointless SBT may expose patients to anxiety, air hunger and dyspnea which are poorly detected by caregivers. The hypothesis of the present project is that in patients who are at low risk of extubation failure, a SBT is useless and once readiness to wean criteria are met, direct extubation would increase the proportion of patients successfully extubated within the 24 hours after randomization as compared to extubation after a successful SBT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Weaning strategy with direct extubation (no spontaneous breathing trial)
Weaning strategy with direct extubation (no spontaneous breathing trial)
Patients will be extubated within the 60 minutes following randomization
Weaning strategy with extubation only after a successful spontaneous breathing
Weaning strategy with extubation only after a successful spontaneous breathing
Patients will undergo a spontaneous breathing trial and will be extubated only in case of successful spontaneous breathing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weaning strategy with direct extubation (no spontaneous breathing trial)
Patients will be extubated within the 60 minutes following randomization
Weaning strategy with extubation only after a successful spontaneous breathing
Patients will undergo a spontaneous breathing trial and will be extubated only in case of successful spontaneous breathing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Nasal or oral intubation longer than 24 hours and less than 4 days
* Satisfaction to each following weaning readiness criteria:
1. Respiratory rate \< 35 cycles per minute
2. SpO2 \>90% with FiO2\<40% and PEEP\<8 cmH2O
3. RASS score between -2 and +2 with low level or no sedatives
4. No need or low doses of vasopressors
5. Adequate cough
* Inform consent by patient or legal representative or the close relative or emergency inclusion procedure.
Exclusion Criteria
* Chronic cardiac disease (left ejection fraction below 45%, documented history of cardiogenic pulmonary edema, permanent atrial fibrillation).
* Chronic respiratory disease (severe COPD, documented restricted lung disease or obesity-hypoventilation syndrome)
* Body mass index \> 30 kg/m2
* Airway patency problems, including high risk of developing laryngeal edema, inability to deal with respiratory secretions, brain injury, documented swallowing disorders
* Tracheostomy
* Underlying chronic neuromuscular disease
* Do not resuscitate orders
* Pregnant or lacting woman
* Patient under guardianship
* Patient without healthcare insurance
* Refusal to participate and sign the written consent
* Patients with traumatic brain injury
* Post surgery patients
* Patients included in another interventional trial that may have an impact on the evaluation criteria of the present study
* Patient under AME
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin DRES, Pr
Role: PRINCIPAL_INVESTIGATOR
Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Pitié Salpêtrière
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00258-41
Identifier Type: OTHER
Identifier Source: secondary_id
APHP240912
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.